Characterization of immune system alterations following preoperative autologous blood donation for elective hip replacement surgery

Transfusion Medicine

Volumn 17, Issue 1, 2007, Pages 45-53

  Karger, R ^a,b   Weber, C ^a   Schmidt, J ^a   Kretschmer, V ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cytokine secretion; Elective orthopaedic surgery; Immunomodulation; Postoperative infectious complication; Preoperative autologous blood donation; Th1 Th2 balance

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; CANCER PATIENT; CANCER RECURRENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTIVE SURGERY; FEMALE; GRANULOCYTE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INNATE IMMUNITY; LEUKOCYTE COUNT; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; T LYMPHOCYTE; TOTAL HIP PROSTHESIS;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD DONORS; BLOOD TRANSFUSION, AUTOLOGOUS; CELLS, CULTURED; COHORT STUDIES; CONCANAVALIN A; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; INFECTION; IRON; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MONOCYTES; PHYTOHEMAGGLUTININS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; SAMPLING STUDIES; SURGICAL PROCEDURES, ELECTIVE; TH1 CELLS; TH2 CELLS;

EID: 33846939506     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2006.00711.x     Document Type: Article

References (45)

1. Ahluwalia, N., Sun, J., Krause, D., Mastro, A. & Handte, G. (2004) Immune function is impaired in iron-deficient, homebound, older women. American Journal of Clinical Nutrition, 75, 516-521.
2. Allen, J.E. & Maizels, R.M. (1997) Th1-Th2: reliable paradigm or dangerous dogma? Immunology Today, 18, 387-392.
3. Altman, D.G. (1991) Practical Statistics for Medical Research. Chapman & Hall, Boca Raton.
4. Angele, M.K. & Faist, E. (2002) Clinical review: immuno-depression in the surgical patient and increased susceptibility to infection. Critical Care, 6, 298-305.
5. Bergman, M., Bessler, H., Salman, H., Siomin, D., Straussberg, R. & Djaldetti, M. (2004) In vitro cytokine production in patients with iron deficiency anemia. Clinical Immunology, 113, 340-344.
6. Bienvenu, J., Monneret, G., Fabien, N. & Revillard, J.P. (2000) The clinical usefulness of the measurement of cytokines. Clinical Chemistry and Laboratory Medicine, 38, 267-285.
7. Bullen, J.J., Rogers, H.J., Spalding, P.B. & Ward, C.G. (2005) Iron and infection: the heart of the matter. FEMS Immunology and Medical Microbiology, 43, 325-330.
8. Chtanova, T. & Mackay, C.R. (2001) T cell effector subsets: extending the Th1/Th2 paradigm. Advances in Immunology, 78, 233-266.
9. Dong, C. & Flavell, R.A. (2001) Th1 and Th2 cells. Current Opinion in Hematology, 8, 47-51.
10. Failla, M.L. (2003) Trace elements and host defense: recent advances and continuing challenges. Journal of Nutrition, 133, 1443S-1447S.
11. Faist, E., Baue, A.E., & Schildberg, F.W. (1996) The Immune Consequences of Trauma, Shock and Sepsis - Mechanisms and Therapeutic Approaches. MOF, MODS and SIRS: Basic Mechanisms in Inflammation and Tissue Injury. Pabst Science Publishers, Lengerich.
12. Federal Physicians Chamber & Paul-Ehrlich-Institute (2000) Directives for the procurement of blood and blood constituents and for the application of blood products (hemotherapy) (German). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz, 43, 555-589.
13. Franchimont, D. (2004) Overview of the actions of glucocorticoids on the immune response. Annals of the New York Academy of Sciences, 1024, 124-137.
14. Geppert, T. (1998) Phytohemagglutinin (PHA). In: Encyclopedia of Immunology (eds Delves, P.J. & Roitt, I.M.), Academic Press, San Diego, 1952-1953.
15. H1-TH2: a Procrustean paradigm. Nature Immunology, 4, 503-505.
16. Heiss, M.M., Mempel, W., Jauch, K.-W., Delanoff, C., Mayer, G., Mempel, M., Eissner, H.-J. & Schildberg, F.-W. (1993) Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet, 342, 1328-1333.
17. Innerhofer, P., Klingler, A., Klimmer, C., Fries, D. & Nussbaumer, W. (2005) Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion, 45, 103-110.
18. Jankovic, D., Liu, Z. & Gause, W.C. (2001) Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends in Immunology, 22, 450-457.
19. Karger, R., Weber, C., Schmidt, J. & Kretschmer, V. (2006) Immunomodulatory effects of non-leukocyte-depleted and leukocyte-depleted autologous blood. Transfusion Medicine and Hemotherapy, 33, 330-335.
20. Kretschmer, V., Weippert-Kretschmer, M., Mortelmans, Y., Huss, B. & Schulzki, T. (1994) Risk assessment and diminution in preoperative autologous blood donation (German). Beiträge zur Infusionstherapie und Transfusionsmedizin, 32, 481-487.
21. Lange, S., Riggert, J., Humpe, A., Dittmann, J., Simson, G. & Köhler, M. (1996) Immunologic effects of blood donation (German). Beiträge zur Infusionstherapie und Transfusionsmedizin, 33, 93-97.
22. Lasek, W., Jakobisiak, K. & Stoklosa, T. (1994) Decreased natural killer cell activity in whole-blood donors does not seem to result in increased cancer incidence. Transfusion, 34, 359-360.
23. Lee, C.C., Chang, I.J., Yen, Z.S. et al. (2005) Effect of different resuscitation fluids on cytokine response in a rat model of hemorrhagic shock. Shock, 24, 177-181.
24. Locksley, R.M., Killeen, N. & Lenardo, M.J. (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell, 104, 487-501.
25. Maes, M., Song, C., Lin, A. et al. (1998) The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine, 10, 313-318.
26. Maes, M., van Bockstaele, D.R., van Gastel, A. et al. (1999) The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation. Neuropsychobiology, 39, 1-9.
27. Maldonado-López, R. & Moser, M. (2001) Dendritic cell subsets and the regulation of Th1/Th2 responses. Seminars in Immunology, 13, 275-282.
28. Marquet, R.L., Hoynck van Papendrecht, M.A., Busch, O.R. & Jeekel, J. (1993) Blood donation leads to a decrease in natural killer cell activity: a study in normal blood donors and cancer patients. Transfusion, 33, 368-373.
29. McGuirk, P. & Mills, K.H.G. (2004) Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends in Immunology, 23, 450-455.
30. Molls, R.R., Ahluwalia, N., Mastro, A.M., Smiciklas-Wright, H. & Handte, G.C. (2005) Nutritional status predicts primary subclasses of T cells and the lymphocyte proliferation response in healthy older women. Journal of Nutrition, 135, 2644-2650.
31. Mosmann, T.R. & Sad, S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today, 17, 138-146.
32. Nadler, S.B., Hidalgo, J.U., & Bloch, T. (1962) Prediction of blood volume in normal human adults. Surgery, 51, 224-232.
33. Neurath, M.F., Finotto, S. & Glimcher, L.H. (2002) The role of Th1/Th2 polarization in mucosal immunity. Nature Medicine, 8, 567-573.
34. Papadakis, K.A. & Targan, S.R. (2000) Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology, 119, 1148-1157.
35. Roitt, I.M. & Delves, J. (2004) Roitt's Essential Immunology (10th edn). Blackwell Science, Oxford.
36. Schaible, U.E. & Kaufmann, S.H.E. (2004) Iron and microbial infection. Nature Reviews. Microbiology, 2, 946-953.
37. Schoeler, M., Weiler-Lorentz, A., Huber, D., Karger, R. & Frietsch, T. (2006) Leukocyte depletion of autologous blood: effects on infection rate and length of hospital stay (abstract). Anesthesiology, 105, A362.
38. Sillett, H.K., Whicher, J.T. & Trejdosiewicz, L.K. (1997) Effect of resuscitation fluids on nonadaptive immune responses. Transfusion, 37, 953-959.
39. Sillett, H.K., Whicher, J.T. & Trejdosiewicz, L.K. (1998) Effects of resuscitation fluids on T cell immune responses. British Journal of Anaesthesia, 81, 242-243.
40. Tian, J., Lin, X., Zhou, W. & Xu, J. (2003) Hydroxyethyl starch inhibits NF-kappaB activation and prevents the expression of inflammatory mediators in endotoxic rats. Annals of Clinical and Laboratory Science, 33, 451-458.
41. Varfolomeev, E.E. & Ashkenazi, A. (2004) Tumor necrosis factor: an apoptosis JuNKie? Cell, 116, 491-497.
42. Volk, H.-D. (2002) Immunodepression in the surgical patient and increased susceptibility to infection (commentary). Critical Care, 6, 279-281.
43. Vyoral, D. & Petrák, J. (2005) Hepcidin: a direct link between iron metabolism and immunity. International Journal of Biochemistry and Cell Biology, 37, 1768-1773.
44. Weiss, G. (2002) Iron and immunity: a double-edged sword. European Journal of Clinical Investigation, 32 (Suppl. I), 70-78.
45. Wilson, B.M.G., Severn, A., Rapson, N.T., Chana, J., & Hopkins, P. (1991) A convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharide. Journal of Immunological Methods, 139, 233-240.